Drug Patents owned by Amneal
1. Drug name - LYVISPAH
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10792262 | AMNEAL | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives |
Jul, 2039
(16 years from now) | |
Drugs and Companies using BACLOFEN ingredient
Treatment: Method for treating spasticity
Dosage: GRANULES;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 5MG/PACKET | GRANULES;ORAL | Prescription |
| 10MG/PACKET | GRANULES;ORAL | Prescription |
| 20MG/PACKET | GRANULES;ORAL | Prescription |
2. Drug name - TIGECYCLINE
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9855335 | AMNEAL | Tigecycline composition for injection |
Apr, 2033
(10 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 50MG/VIAL | POWDER;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.